Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2020

View Archived Issues

Atherosclerosis, AD meet at the myelin

p53 loss leads to immune evasion

Karus Therapeutics initiates phase II study of KA-2507 in biliary tract cancer

Enrollment open in phase II study of MSTT-1041A or UTTR-1147A in COVID-19 pneumonia

Clinical data for novel non-D2-receptor-binding compound in patients with schizophrenia

DNA-encoded immunotherapies show efficacy in models of N. gonorrhoeae infection

First-in-human characterization of RPT-193

IRAK-2 is a therapeutic target in atopic dermatitis and psoriasis

AiCuris discovers HBV caspid assembly inhibitors

New SSAO inhibitors identified at Boehringer Ingelheim

Esteve patents voltage-dependent calcium channel subunit alpha2/delta-1 ligands

Merck & Co. identifies new LRRK2 inhibitors

New TYK2 inhibitors disclosed by Bristol-Myers Squibb

Germline ApoE variants affect melanoma trajectory

PEG10 found behind pathogenic mechanisms of mycosis fungoides

Phase III trial of efgartigimod in generalized myasthenia gravis meets primary endpoint

Chi-Med and BeiGene to study surufatinib and fruquintinib with tislelizumab for solid tumors

Synairgen's phase II trial begins dosing SNG-001 in home setting to treat COVID-19

Novartis begins phase II study of DFV-890 for COVID-19 pneumonia

Glenmark to begin phase III study of favipiravir with umifenovir in moderate COVID-19

Tavotek and Genmab partner to develop antibody for autoimmune and inflammatory conditions

Levels of cytokine LIGHT correlate with disease severity and mortality in COVID-19 ARDS study

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...